Role of mitochondrial DNA mutations in brain tumors: A mini-review

Area of Science:

• Neuro-oncology
• Mitochondrial biology
• Cancer genetics

Background:

• Brain tumors are molecularly diverse, with nuclear gene alterations recognized as key drivers.
• The role of mitochondrial DNA (mtDNA) in brain tumorigenesis remains largely controversial.
• Mitochondria possess unique characteristics, including high mutation susceptibility and inefficient DNA repair, suggesting their potential involvement in cancer.

Purpose of the Study:

• To review the role of mitochondrial DNA (mtDNA) in the development and progression of brain tumors.
• To explore the potential of mtDNA mutations as biomarkers for brain cancer detection, prognosis, and treatment response.
• To highlight the significance of mitochondrial function in brain tumor etiology.

Main Methods:

• Literature review focusing on mitochondrial DNA (mtDNA) alterations in brain tumors.
• Analysis of existing research on mtDNA mutation mechanisms and their link to carcinogenesis.
• Synthesis of evidence regarding the diagnostic and prognostic value of mtDNA defects.

Main Results:

• Mitochondrial DNA (mtDNA) mutations are increasingly suspected to contribute to brain tumor formation.
• mtDNA's high mutation rate and inefficient repair mechanisms make it vulnerable to alterations during carcinogenesis.
• mtDNA mutations may serve as effective molecular biomarkers for brain cancer detection and patient stratification.

Conclusions:

• Mitochondrial DNA (mtDNA) alterations represent a promising area of investigation in neuro-oncology.
• Defects in mtDNA could play a significant role in brain tumor initiation and progression.
• Understanding mtDNA's role may pave the way for novel therapeutic strategies targeting brain tumors.